These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24083703)

  • 1. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
    Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
    Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010.
    Wong YF; Yusof MM; Wan Ishak WZ; Alip A; Phua VC
    Asian Pac J Cancer Prev; 2015; 16(7):2903-8. PubMed ID: 25854381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in nasopharyngeal carcinoma: Results from a nonendemic cohort.
    Laskar SG; Gurram L; Gupta T; Budrukkar A; Murthy V; Agarwal JP
    Indian J Cancer; 2016; 53(4):493-498. PubMed ID: 28485337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
    Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
    Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
    Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
    Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
    Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
    Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome with brachytherapy for recurrent nasopharyngeal carcinoma.
    Cheah SK; Lau FN; Yusof MM; Phua VC
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6513-8. PubMed ID: 24377559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO).
    Tonoli S; Alterio D; Caspiani O; Bacigalupo A; Bunkheila F; Cianciulli M; Merlotti A; Podhradska A; Rampino M; Cante D; Bruschieri L; Gatta R; Magrini SM
    Strahlenther Onkol; 2016 Dec; 192(12):931-943. PubMed ID: 27761611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes.
    Xu T; Zhu G; He X; Ying H; Hu C
    Oral Oncol; 2014 Feb; 50(2):71-6. PubMed ID: 24315404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients.
    Liu W; Tang Y; Gao L; Huang X; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G; Yi J
    Radiat Oncol; 2014 Dec; 9():274. PubMed ID: 25477058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.
    Prasad U; Wahid MI; Jalaludin MA; Abdullah BJ; Paramsothy M; Abdul-Kareem S
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):648-55. PubMed ID: 12062608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.